GlassScriptPhysician profile
Jeffrey K Evans
NPI 1588683510
$1,836.27
in general payments reported to CMS, 2019-2025
16 companies · $146 in 2025
The $146 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $240 · 2020: $134 · 2021: $107 · 2022: $107 · 2023: $723 · 2024: $380 · 2025: $146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $860 · Travel and Lodging: $388.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $860.39 |
| Travel and Lodging | $388.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,137.84 | 2019-2024 | Blueprint Patient Specific Instrumentation, T2 |
| Wright Medical Technology, INC. | $121.09 | 2020 | |
| Zimmer Biomet Holdings, INC. | $92.08 | 2025 | Persona |
| Djo, LLC | $76.63 | 2023-2024 | Cmf |
| Ferring Pharmaceuticals INC. | $75.37 | 2019-2025 | Adstiladrin |
| Midsouth Orthopedics INC. | $62.63 | 2023 | |
| Pacira Therapeutics, INC. | $53.53 | 2019 | |
| Depuy Synthes Sales INC. | $36.49 | 2023 | Va-Lcp, Na |
| Kerecis Limited | $31.31 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Bioventus LLC | $31.05 | 2019-2024 | Durolane |
| Abbvie INC. | $30.73 | 2023 | |
| Kci USA, INC. | $24.81 | 2023 | V.A.C. Veraflo Cleanse Choice, Prevena |
| Horizon Therapeutics Plc | $21.22 | 2022 | |
| Pfizer INC. | $15.05 | 2021 | |
| Boston Scientific Corporation | $14.64 | 2025 | Acquire |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $11.80 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Evans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.